Sickle cell cholangiopathy: An endoscopic retrograde cholangiopancreatography evaluation

Table 1 ERCP findings in patients with cholestatic jaundice only (Total No. of patients = 79)

Finding	n (%)
Normal	42 (53.2)
Dilated CBD without stones	11 (13.9)
Dilated CBD with stones	10 (12.7)
Dilated bile ducts with stones	6 (7.6)
Dilated bile ducts without stones	1 (1.3)
Dilated CHD without stones	1 (1.3)
Normal CBD with stones	1 ( 1.3)
Edematous inflamed papilla	4 (5.1)

ERCP: Endoscopic retrograde cholangiopancreatography; CBD: Common bile duct; CHD: Common hepatic duct.

Table 2 ERCP findings in patients with cholestatic jaundice and dilated bile ducts on ultrasound (Total No. of patients = 103)

Finding	n (%)
Normal	17 (16.5)
Dilated CBD without stones	17 (16.5)
Dilated CBD with stones	30 (29.13)
Dilated bile ducts without stones	11 (10.7)
Dilated bile ducts with stones	17 (16.5)
Normal CBD with a stone	1 (0.98)
Choledochoduodenal fistula	2 (1.94)
Edematous inflamed papilla	8 (7.8)

Table 3 ERCP findings in patients with cholestatic jaundice and bile duct stones (Total No. of patients = 42)

Finding	n (%)
Normal	2 (4.8)
Dilated CBD without stones	7 (16.7)
Dilated CBD with stones	14 (33.3)
Dilated bile ducts without stones	7 (16.7)
Dilated bile ducts with stones	7 (16.7)
Normal CBD with a stone	1 (2.4)
Edematous inflamed papilla	4 (9.5)

Table 4 Therapeutic procedures during ERCP

Procedure	n (%)
Endoscopic sphincterotomy only	42 (18.8)
Endoscopic sphincterotomy and stone extraction	79 (35.3)
Insertion of biliary stent	8 (3.6)
Endoscopic sphincterotomy, mechanical lithotripsy, and stone extraction	4 (1.8)
Insertion of a nasobiliary tube	4 (1.8)